Commonwealth Equity Services
BIO icon

Commonwealth Equity Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Commonwealth Equity Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
1,097
-26
-2% -$7.38K ﹤0.01% 3711
2026
Q1 		$313K Sell
1,123
-15
-1% -$4.32K ﹤0.01% 3628
2025
Q4 		$345K Sell
1,138
-45
-4% -$14K ﹤0.01% 3538
2025
Q3 		$332K Buy
1,183
+40
+3% +$10.9K ﹤0.01% 3535
2025
Q2 		$276K Buy
+1,143
New +$270K ﹤0.01% 3669
2024
Q2 		– Sell
-2,114
Closed -$731K – 4054
2024
Q1 		$731K Buy
+2,114
New +$695K ﹤0.01% 2484
2023
Q4 		– Sell
-674
Closed -$242K – 3916
2023
Q3 		$242K Sell
674
-47
-7% -$18.1K ﹤0.01% 3214
2023
Q2 		$273K Buy
721
+38
+6% +$15.5K ﹤0.01% 3131
2023
Q1 		$327K Sell
683
-54
-7% -$25.3K ﹤0.01% 2897
2022
Q4 		$309K Sell
737
-255
-26% -$103K ﹤0.01% 2843
2022
Q3 		$413K Buy
992
+21
+2% +$10.5K ﹤0.01% 2570
2022
Q2 		$480K Buy
971
+275
+40% +$143K ﹤0.01% 2434
2022
Q1 		$392K Buy
696
+33
+5% +$19.9K ﹤0.01% 2731
2021
Q4 		$500K Sell
663
-209
-24% -$156K ﹤0.01% 2517
2021
Q3 		$650K Sell
872
-57
-6% -$42.7K ﹤0.01% 2273
2021
Q2 		$598K Buy
929
+113
+14% +$68.8K ﹤0.01% 2327
2021
Q1 		$466K Sell
816
-478
-37% -$283K ﹤0.01% 2388
2020
Q4 		$754K Sell
1,294
-548
-30% -$312K ﹤0.01% 1854
2020
Q3 		$949K Buy
1,842
+1,065
+137% +$539K ﹤0.01% 1531
2020
Q2 		$350K Buy
777
+44
+6% +$19.4K ﹤0.01% 2153
2020
Q1 		$256K Sell
733
-39
-5% -$14.3K ﹤0.01% 2184
2019
Q4 		$285K Sell
772
-4
-0.5% -$1.41K ﹤0.01% 2360
2019
Q3 		$258K Buy
+776
New +$253K ﹤0.01% 2364
2018
Q4 		– Sell
-708
Closed -$221K – 2689
2018
Q3 		$221K Sell
708
-5
-0.7% -$1.55K ﹤0.01% 2418
2018
Q2 		$206K Buy
+713
New +$197K ﹤0.01% 2438

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Commonwealth Equity Services's BIO Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Bio-Rad Laboratories Class A (BIO) stake by 2.3% in Q2 2026, selling an estimated $7.38K and leaving 1,097 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

Commonwealth Equity Services first reported a position in BIO in Q2 2018 and has held it in 25 quarters since. The position peaked at $949K in Q3 2020. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Commonwealth Equity Services held 1,097 shares of Bio-Rad Laboratories Class A worth $322K as of Q2 2026.
  • Commonwealth Equity Services sold 26 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $7.38K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3711 holding.
  • Commonwealth Equity Services first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and has held it in 25 quarters since.
  • Commonwealth Equity Services's Bio-Rad Laboratories Class A position peaked at $949K in Q3 2020.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.